Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
2+ day, 16+ hour ago (778+ words) The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who…...
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
3+ day, 20+ hour ago (184+ words) New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline CAR…...
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer
3+ day, 22+ hour ago (801+ words) The FDA has cleared a CU Anschutz clinical trial of an experimental CAR T-cell therapy for advanced colorectal cancer and pediatric solid tumors. Developed at CU Anschutz, the therapy targets two pathways that help tumors grow and evade the immune…...
Rare Muscle-Infiltrating T-Cell Lymphoma in a Dog Challenges Diagnosis
3+ day, 17+ hour ago (85+ words) A ten-year-old castrated male mixed breed dog walked into his routine wellness visit with what looked like a minor soft tissue problem: mild swelling around the right hock. Within days, that swelling had exploded into severe pitting edema along an…...
FDA Approves CAR T-Cell Trials for Colorectal Cancer
3+ day, 23+ hour ago (737+ words) The U.S. Food and Drug Administration has granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who have…...
Measuring how target antigen levels drive CAR T-cell efficacy in AML
4+ day, 14+ hour ago (857+ words) Bioengineer.org...
Patient with AL Amyloidosis Experiences Complete Remission after CAR T-Cell Therapy
5+ day, 11+ hour ago (607+ words) Treatment yields positive results despite late diagnosis and cardiac involvement AL amyloidosis is a complex disease that’s vexing to diagnose. The diagnostic journey can exceed 15 years in some cases. In this instance, a woman in her 50s had struggled with low…...
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
5+ day, 10+ hour ago (152+ words) IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ — PeproMene Bio, Inc. today announced the publication in The Lancet, one of the world’s leading medical journals, of results from its Phase 1 clinical trial evaluating PMB-CT01, the company’s first-in-class BAFF-R-targeted CAR T-cell therapy, in patients with…...
CAR-T Therapy
6+ day, 2+ hour ago (252+ words) Whether you are part of our community or are interested in joining us, we welcome you to WashU Medicine. A game-changing innovation in blood cancer treatment An innovative cell-based immunotherapy developed by WashU Medicine researchers is changing the paradigm of…...
Cheaper CAR-T therapy drawing global cancer patients to China
6+ day, 6+ hour ago (869+ words) At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to US$600,000 for CAR-T therapy. He paid less than half that in Shanghai and learned on August 18 that his cancer was in complete…...